Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00975884
First received: September 11, 2009
Last updated: September 29, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 2, 2010
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):